Juan D. Chaparro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan D. Chaparro has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Charlie Macias
Quality Improvement Service; Nationwide Children’s Hospital, Columbus, Ohio
2 shared publications- Cleo K. Maehara
Medical and Imaging Informatics, Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA
2 shared publications Cory Hussain
Denver Health
2 shared publicationsJessica Hehmeyer
Nationwide Children
2 shared publicationsSon Doan
University of California San Diego, La Jolla, CA
2 shared publicationsAdam C. Dziorny
Department of Pediatrics, University of Rochester School of Medicine, Rochester, New York, United States
1 shared publication
Latest Publications
- Open Access
- 27 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Bytes to Bedside: Protocol for a Multi-Site Mixed-Methods Study for Development and Evaluation of a Collaborative Framework for Clinical Decision Support Evaluation (Preprint)
BACKGROUND Clinical Decision Support (CDS) systems are crucial for translating research findings into clinical practice. However, the effectiveness of CDS varies significantly, and a comprehensive evaluation framework is necessary to predict successful implementation. This study aims to address these gaps through a collaborative effort to standardize CDS evaluation across multiple sites. OBJECTIVE The objectives of this study are to (1) develop an evaluation framework for CDS across collaboration sites and (2) determine whether a collaborative CDS analytics platform improves CDS evaluation efficiency and completeness. METHODS Leveraging the EPIS (Exploration, Preparation, Implementation, Sustainment) framework, we will establish a multi-site collaborative framework for CDS evaluation. This study will develop a common evaluation framework and an innovative CDS analytics platform. Our mixed-methods approach includes forming a governance structure and workgroups to facilitate collaboration and using a modified Delphi process to develop a consensus approach to pragmatic CDS evaluation. We will then conduct a randomized, incomplete block design study to compare the efficiency and completeness of CDS evaluations across collaborating and non-collaborating sites. RESULTS As of August, 2026, the pediatric CDS collaborative includes 20 health systems and has been formalizing governance structures and standing committees. During the UG3 phase, we anticipate completing selection of eight representative CDS use cases, developing a consensus CDS evaluation framework, and designing and usability-testing a CDS evaluation dashboard and centralized analytics platform. No outcome data are available at this stage. CONCLUSIONS By establishing a standardized evaluation framework and a centralized analytics platform, the collaborative seeks to transform CDS design into a predictive science. This initiative will provide a scalable model for CDS evaluation, facilitating the rapid translation of research evidence into clinical practice across diverse healthcare settings.
- 27 August 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessBytes to Bedside: Protocol for a Multi-Site Mixed-Methods Study for Development and Evaluation of a Collaborative Framework for Clinical Decision Support Evaluation (Preprint)
BACKGROUND Clinical Decision Support (CDS) systems are crucial for translating research findings into clinical practice. However, the effectiveness of CDS varies significantly, and a comprehensive evaluation framework is necessary to predict successful implementation. This study aims to address these gaps through a collaborative effort to standardize CDS evaluation across multiple sites. OBJECTIVE The objectives of this study are to (1) develop an evaluation framework for CDS across collaboration sites and (2) determine whether a collaborative CDS analytics platform improves CDS evaluation efficiency and completeness. METHODS Leveraging the EPIS (Exploration, Preparation, Implementation, Sustainment) framework, we will establish a multi-site collaborative framework for CDS evaluation. This study will develop a common evaluation framework and an innovative CDS analytics platform. Our mixed-methods approach includes forming a governance structure and workgroups to facilitate collaboration and using a modified Delphi process to develop a consensus approach to pragmatic CDS evaluation. We will then conduct a randomized, incomplete block design study to compare the efficiency and completeness of CDS evaluations across collaborating and non-collaborating sites. RESULTS As of August, 2026, the pediatric CDS collaborative includes 20 health systems and has been formalizing governance structures and standing committees. During the UG3 phase, we anticipate completing selection of eight representative CDS use cases, developing a consensus CDS evaluation framework, and designing and usability-testing a CDS evaluation dashboard and centralized analytics platform. No outcome data are available at this stage. CONCLUSIONS By establishing a standardized evaluation framework and a centralized analytics platform, the collaborative seeks to transform CDS design into a predictive science. This initiative will provide a scalable model for CDS evaluation, facilitating the rapid translation of research evidence into clinical practice across diverse healthcare settings.
- 25 May 2022
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 13 (03) , 560-568
Clinical Decision Support Stewardship: Best Practices and Techniques to Monitor and Improve Interruptive Alerts
Interruptive clinical decision support systems, both within and outside of electronic health records, are a resource that should be used sparingly and monitored closely. Excessive use of interruptive alerting can quickly lead to alert fatigue and decreased effectiveness and ignoring of alerts. In this review, we discuss the evidence for effective alert stewardship as well as practices and methods we have found useful to assess interruptive alert burden, reduce excessive firings, optimize alert effectiveness, and establish quality governance at our institutions. We also discuss the importance of a holistic view of the alerting ecosystem beyond the electronic health record.
- 25 May 2022
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 13 (03) , 560-568
Clinical Decision Support Stewardship: Best Practices and Techniques to Monitor and Improve Interruptive Alerts
Interruptive clinical decision support systems, both within and outside of electronic health records, are a resource that should be used sparingly and monitored closely. Excessive use of interruptive alerting can quickly lead to alert fatigue and decreased effectiveness and ignoring of alerts. In this review, we discuss the evidence for effective alert stewardship as well as practices and methods we have found useful to assess interruptive alert burden, reduce excessive firings, optimize alert effectiveness, and establish quality governance at our institutions. We also discuss the importance of a holistic view of the alerting ecosystem beyond the electronic health record.
- 11 January 2022
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (2) , 172-174
Fever of Unknown Origin in a 6-Year-old
- 11 January 2022
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 42 (2) , 172-174
Fever of Unknown Origin in a 6-Year-old
- Open Access
- 1 May 2020
- Published by Wolters Kluwer Health in Pediatric Quality & Safety
- Vol. 5 (3) , e301
Improving Early Discharges With an Electronic Health Record Discharge Optimization Tool
Introduction: Delays in hospital discharge can negatively impact patient care, bed availability, and patient satisfaction. There are limited studies examining how the electronic health record (EHR) can be used to improve discharge timeliness. This study aimed to implement an EHR discharge optimization tool (DOT) successfully and achieve a discharge before noon (DBN) percentage of 25%. Methods: We conducted a single-center quality improvement study of patients discharged from 3 pediatric hospital medicine teaching service teams at a quaternary care academic children’s hospital. The multidisciplinary team created a DOT centrally embedded within the care team standard workflow to communicate anticipated time until discharge. The primary outcome was the monthly percentage of patients discharged before noon. Secondary outcomes included provider utilization of the DOT, tool accuracy, and patient length of stay. Balancing measures were 7- and 30-day readmission rates. Results: The DBN percentage increased from 16.4% to an average of 19.3% over the 13-month intervention period (P = 0.0005). DOT utilization was measured at 87.2%, and the overall accuracy of predicting time until discharge was 75.6% (P < 0.0001). Median length of stay declined from 1.75 to 1.68 days (P = 0.0033), and there was no negative impact on 7- or 30-day readmission rates. Conclusion: This initiative demonstrated that a highly utilized and accurate discharge tool could be created in the EHR to assist medical care teams with improving DBN percentage on busy, academic teaching services.
- 1 May 2020
- Published by Wolters Kluwer Health in Pediatric Quality & Safety
- Vol. 5 (3) , e301
Open AccessImproving Early Discharges With an Electronic Health Record Discharge Optimization Tool
Introduction: Delays in hospital discharge can negatively impact patient care, bed availability, and patient satisfaction. There are limited studies examining how the electronic health record (EHR) can be used to improve discharge timeliness. This study aimed to implement an EHR discharge optimization tool (DOT) successfully and achieve a discharge before noon (DBN) percentage of 25%. Methods: We conducted a single-center quality improvement study of patients discharged from 3 pediatric hospital medicine teaching service teams at a quaternary care academic children’s hospital. The multidisciplinary team created a DOT centrally embedded within the care team standard workflow to communicate anticipated time until discharge. The primary outcome was the monthly percentage of patients discharged before noon. Secondary outcomes included provider utilization of the DOT, tool accuracy, and patient length of stay. Balancing measures were 7- and 30-day readmission rates. Results: The DBN percentage increased from 16.4% to an average of 19.3% over the 13-month intervention period (P = 0.0005). DOT utilization was measured at 87.2%, and the overall accuracy of predicting time until discharge was 75.6% (P < 0.0001). Median length of stay declined from 1.75 to 1.68 days (P = 0.0033), and there was no negative impact on 7- or 30-day readmission rates. Conclusion: This initiative demonstrated that a highly utilized and accurate discharge tool could be created in the EHR to assist medical care teams with improving DBN percentage on busy, academic teaching services.
- Open Access
- 1 February 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (2) , AB99
Development of a Penicillin Allergy Electronic Decision Support Pathway for Pediatric Inpatient Admissions
- 1 February 2020
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (2) , AB99
Open AccessDevelopment of a Penicillin Allergy Electronic Decision Support Pathway for Pediatric Inpatient Admissions
- 1 January 2020
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 11 (01) , 046-058
Reducing Interruptive Alert Burden Using Quality Improvement Methodology
Background Increased adoption of electronic health records (EHR) with integrated clinical decision support (CDS) systems has reduced some sources of error but has led to unintended consequences including alert fatigue. The “pop-up” or interruptive alert is often employed as it requires providers to acknowledge receipt of an alert by taking an action despite the potential negative effects of workflow interruption. We noted a persistent upward trend of interruptive alerts at our institution and increasing requests for new interruptive alerts. Objectives Using Institute for Healthcare Improvement (IHI) quality improvement (QI) methodology, the primary objective was to reduce the total volume of interruptive alerts received by providers. Methods We created an interactive dashboard for baseline alert data and to monitor frequency and outcomes of alerts as well as to prioritize interventions. A key driver diagram was developed with a specific aim to decrease the number of interruptive alerts from a baseline of 7,250 to 4,700 per week (35%) over 6 months. Interventions focused on the following key drivers: appropriate alert display within workflow, clear alert content, alert governance and standardization, user feedback regarding overrides, and respect for user knowledge. Results A total of 25 unique alerts accounted for 90% of the total interruptive alert volume. By focusing on these 25 alerts, we reduced interruptive alerts from 7,250 to 4,400 per week. Conclusion Systematic and structured improvements to interruptive alerts can lead to overall reduced interruptive alert burden. Using QI methods to prioritize our interventions allowed us to maximize our impact. Further evaluation should be done on the effects of reduced interruptive alerts on patient care outcomes, usability heuristics on cognitive burden, and direct feedback mechanisms on alert utility.
- 1 January 2020
- Published by Georg Thieme Verlag KG in Applied Clinical Informatics
- Vol. 11 (01) , 046-058
Reducing Interruptive Alert Burden Using Quality Improvement Methodology
Background Increased adoption of electronic health records (EHR) with integrated clinical decision support (CDS) systems has reduced some sources of error but has led to unintended consequences including alert fatigue. The “pop-up” or interruptive alert is often employed as it requires providers to acknowledge receipt of an alert by taking an action despite the potential negative effects of workflow interruption. We noted a persistent upward trend of interruptive alerts at our institution and increasing requests for new interruptive alerts. Objectives Using Institute for Healthcare Improvement (IHI) quality improvement (QI) methodology, the primary objective was to reduce the total volume of interruptive alerts received by providers. Methods We created an interactive dashboard for baseline alert data and to monitor frequency and outcomes of alerts as well as to prioritize interventions. A key driver diagram was developed with a specific aim to decrease the number of interruptive alerts from a baseline of 7,250 to 4,700 per week (35%) over 6 months. Interventions focused on the following key drivers: appropriate alert display within workflow, clear alert content, alert governance and standardization, user feedback regarding overrides, and respect for user knowledge. Results A total of 25 unique alerts accounted for 90% of the total interruptive alert volume. By focusing on these 25 alerts, we reduced interruptive alerts from 7,250 to 4,400 per week. Conclusion Systematic and structured improvements to interruptive alerts can lead to overall reduced interruptive alert burden. Using QI methods to prioritize our interventions allowed us to maximize our impact. Further evaluation should be done on the effects of reduced interruptive alerts on patient care outcomes, usability heuristics on cognitive burden, and direct feedback mechanisms on alert utility.
- Open Access
- 22 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0193982
Two key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis
Although toxoplasmosis is one of the most common parasitic infections worldwide, therapeutic options remain limited. Cathepsins, proteases that play key roles in the pathogenesis of toxoplasmosis and many other protozoan infections, are important potential therapeutic targets. Because both TgCPB and TgCPL play a role in T. gondii invasion, we evaluated the efficacy of the potent, irreversible vinyl sulfone inhibitor, K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl). The inhibitor’s toxicity and pharmacokinetic profile have been well-studied because of its in vitro and in vivo activity against a number of parasites. We found that it inhibited both TgCPB (EC50 = 114 nM) and TgCPL (EC50 = 71 nM) in vitro. K11777 also inhibited invasion of human fibroblasts by RH tachyzoites by 71% (p = 0.003) and intracellular replication by >99% (pIn vivo, a single dose of K11777 led to 100% survival of chicken embryos in an model of acute toxoplasmosis (p = 0.015 Cox regression analysis). Therefore, K11777 shows promise as a novel therapeutic agent in the treatment of toxoplasmosis, and may prove to be a broadly effective anti-parasitic agent.
- 22 March 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (3) , e0193982
Open AccessTwo key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis
Although toxoplasmosis is one of the most common parasitic infections worldwide, therapeutic options remain limited. Cathepsins, proteases that play key roles in the pathogenesis of toxoplasmosis and many other protozoan infections, are important potential therapeutic targets. Because both TgCPB and TgCPL play a role in T. gondii invasion, we evaluated the efficacy of the potent, irreversible vinyl sulfone inhibitor, K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl). The inhibitor’s toxicity and pharmacokinetic profile have been well-studied because of its in vitro and in vivo activity against a number of parasites. We found that it inhibited both TgCPB (EC50 = 114 nM) and TgCPL (EC50 = 71 nM) in vitro. K11777 also inhibited invasion of human fibroblasts by RH tachyzoites by 71% (p = 0.003) and intracellular replication by >99% (pIn vivo, a single dose of K11777 led to 100% survival of chicken embryos in an model of acute toxoplasmosis (p = 0.015 Cox regression analysis). Therefore, K11777 shows promise as a novel therapeutic agent in the treatment of toxoplasmosis, and may prove to be a broadly effective anti-parasitic agent.
- 24 October 2017
- Published by SAGE Publications in Surgical Infections
- Vol. 18 (8) , 894-903
Low Infection-Related Re-Admission Rates in a Retrospective of 4725 Children with Appendicitis Using a Clinical Pathway in a Tertiary Care Pediatric Center
Background: Standardization of antibiotic management of appendicitis in tertiary care pediatric centers has been associated with improved outcomes. Rady Children's Hospital-San Diego implemented an appendicitis clinical pathway in 2005. We evaluated infection-related re-admission risk factors since 2010, when an electronic medical record was established, with the aim to optimize the clinical pathway. Methods: Between January 2010 and August 2015, 4725 children with a diagnosis of appendicitis were evaluated for demographic data, pathology diagnoses, culture results, and inpatient and oral step-down antibiotic therapy regimens. From children originally admitted for appendicitis, those who were re-admitted with infection were compared with those who were not re-admitted for infection. The populations were controlled by severity of infection using a pathology-defined appendicitis severity scale: Grade 0, no appendicitis; grade 1, simple acute appendicitis with gross and microscopic evidence of inflammation, but no perforation; grade 2, gangrenous/necrotizing/micro-perforated appendicitis with subserosal or serosal exudate, but no frank or visually appreciated perforation; and grade 3, frank perforation. Results: Of 4725 children (total population, TP) admitted with a diagnosis of appendicitis, only 199 (4.2%) were re-admitted, with 125 of these admissions for infection (2.65% of the TP). Age, race/ethnicity, language preference, and body mass index were not found to correlate with re-admission for infection. Length of stay significantly differed between the no infection-related re-admission population and infection-related re-admission population (3.02 vs. 4.03 d, p < 0.001). There was a trend toward higher infection–re-admission rates as the pathology grade increased (odds ratio grade 1 vs. grade 3 = 2.28, 95% confidence interval 1.03, 5.03). Conclusions: Infection-related re-admission rates for children on the clinical pathway in our institution were infrequent. The greater association of all-cause and infection-related re-admission rates with pathology grade suggest that defining appendicitis by pathology and clinical severity may provide an evidence-based scoring system to support clinical observation in the use and duration of antibiotic therapy.
- 24 October 2017
- Published by SAGE Publications in Surgical Infections
- Vol. 18 (8) , 894-903
Low Infection-Related Re-Admission Rates in a Retrospective of 4725 Children with Appendicitis Using a Clinical Pathway in a Tertiary Care Pediatric Center
Background: Standardization of antibiotic management of appendicitis in tertiary care pediatric centers has been associated with improved outcomes. Rady Children's Hospital-San Diego implemented an appendicitis clinical pathway in 2005. We evaluated infection-related re-admission risk factors since 2010, when an electronic medical record was established, with the aim to optimize the clinical pathway. Methods: Between January 2010 and August 2015, 4725 children with a diagnosis of appendicitis were evaluated for demographic data, pathology diagnoses, culture results, and inpatient and oral step-down antibiotic therapy regimens. From children originally admitted for appendicitis, those who were re-admitted with infection were compared with those who were not re-admitted for infection. The populations were controlled by severity of infection using a pathology-defined appendicitis severity scale: Grade 0, no appendicitis; grade 1, simple acute appendicitis with gross and microscopic evidence of inflammation, but no perforation; grade 2, gangrenous/necrotizing/micro-perforated appendicitis with subserosal or serosal exudate, but no frank or visually appreciated perforation; and grade 3, frank perforation. Results: Of 4725 children (total population, TP) admitted with a diagnosis of appendicitis, only 199 (4.2%) were re-admitted, with 125 of these admissions for infection (2.65% of the TP). Age, race/ethnicity, language preference, and body mass index were not found to correlate with re-admission for infection. Length of stay significantly differed between the no infection-related re-admission population and infection-related re-admission population (3.02 vs. 4.03 d, p < 0.001). There was a trend toward higher infection–re-admission rates as the pathology grade increased (odds ratio grade 1 vs. grade 3 = 2.28, 95% confidence interval 1.03, 5.03). Conclusions: Infection-related re-admission rates for children on the clinical pathway in our institution were infrequent. The greater association of all-cause and infection-related re-admission rates with pathology grade suggest that defining appendicitis by pathology and clinical severity may provide an evidence-based scoring system to support clinical observation in the use and duration of antibiotic therapy.
- Open Access
- 13 June 2017
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 3 (2) , e35
How Do You #relax When You’re #stressed? A Content Analysis and Infodemiology Study of Stress-Related Tweets
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- 13 June 2017
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 3 (2) , e35
Open AccessHow Do You #relax When You’re #stressed? A Content Analysis and Infodemiology Study of Stress-Related Tweets
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- 1 March 2017
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 24 (2) , 268-274
National trends in safety performance of electronic health record systems in children’s hospitals
Objective: To evaluate the safety of computerized physician order entry (CPOE) and associated clinical decision support (CDS) systems in electronic health record (EHR) systems at pediatric inpatient facilities in the US using the Leapfrog Group’s pediatric CPOE evaluation tool. Methods: The Leapfrog pediatric CPOE evaluation tool, a previously validated tool to assess the ability of a CPOE system to identify orders that could potentially lead to patient harm, was used to evaluate 41 pediatric hospitals over a 2-year period. Evaluation of the last available test for each institution was performed, assessing performance overall as well as by decision support category (eg, drug-drug, dosing limits). Longitudinal analysis of test performance was also carried out to assess the impact of testing and the overall trend of CPOE performance in pediatric hospitals. Results: Pediatric CPOE systems were able to identify 62% of potential medication errors in the test scenarios, but ranged widely from 23–91% in the institutions tested. The highest scoring categories included drug-allergy interactions, dosing limits (both daily and cumulative), and inappropriate routes of administration. We found that hospitals with longer periods since their CPOE implementation did not have better scores upon initial testing, but after initial testing there was a consistent improvement in testing scores of 4 percentage points per year. Conclusions: Pediatric computerized physician order entry (CPOE) systems on average are able to intercept a majority of potential medication errors, but vary widely among implementations. Prospective and repeated testing using the Leapfrog Group’s evaluation tool is associated with improved ability to intercept potential medication errors.
- 1 March 2017
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 24 (2) , 268-274
National trends in safety performance of electronic health record systems in children’s hospitals
Objective: To evaluate the safety of computerized physician order entry (CPOE) and associated clinical decision support (CDS) systems in electronic health record (EHR) systems at pediatric inpatient facilities in the US using the Leapfrog Group’s pediatric CPOE evaluation tool. Methods: The Leapfrog pediatric CPOE evaluation tool, a previously validated tool to assess the ability of a CPOE system to identify orders that could potentially lead to patient harm, was used to evaluate 41 pediatric hospitals over a 2-year period. Evaluation of the last available test for each institution was performed, assessing performance overall as well as by decision support category (eg, drug-drug, dosing limits). Longitudinal analysis of test performance was also carried out to assess the impact of testing and the overall trend of CPOE performance in pediatric hospitals. Results: Pediatric CPOE systems were able to identify 62% of potential medication errors in the test scenarios, but ranged widely from 23–91% in the institutions tested. The highest scoring categories included drug-allergy interactions, dosing limits (both daily and cumulative), and inappropriate routes of administration. We found that hospitals with longer periods since their CPOE implementation did not have better scores upon initial testing, but after initial testing there was a consistent improvement in testing scores of 4 percentage points per year. Conclusions: Pediatric computerized physician order entry (CPOE) systems on average are able to intercept a majority of potential medication errors, but vary widely among implementations. Prospective and repeated testing using the Leapfrog Group’s evaluation tool is associated with improved ability to intercept potential medication errors.